EDITAS MEDICINE INC.
2.2400
29-11月-24 12:45:00
15 分の遅延
株式
+0.0400
+1.82%
本日の幅
2.2050 - 2.2800
ISIN
N/A
ソース
NASDAQ
-
Editas Medicine Announces First Quarter 2021 Results and Update
05 5 2021 06:00:01 提供 Nasdaq GlobeNewswire
-
Editas Medicine Names Mark S. Shearman, Ph.D., as Chief Scientific Officer
05 5 2021 05:59:00 提供 Nasdaq GlobeNewswire
-
Editas Medicine to Host Conference Call Discussing First Quarter 2021 Results and Corporate Update
28 4 2021 06:01:00 提供 Nasdaq GlobeNewswire
-
Editas Medicine Announces Fourth Quarter and Full Year 2020 Results and Update
25 2 2021 06:00:03 提供 Nasdaq GlobeNewswire
-
18 2 2021 15:02:00 提供 Nasdaq GlobeNewswire
-
Editas Medicine Announces Appointment of James C. Mullen as Chief Executive Officer
08 2 2021 07:00:00 提供 Nasdaq GlobeNewswire
-
Editas Medicine Announces Pricing of Offering of Common Stock
20 1 2021 21:30:00 提供 Nasdaq GlobeNewswire